Centene Corp（CNC）财务数据CNCCentene Corp

Centene Corp (CNC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Medicaid, accounting for 59.7% of total sales, equivalent to $31.97B. Other significant revenue streams include Medicare and Commercial. Understanding this composition is critical for investors evaluating how CNC navigates market cycles within the Managed Healthcare industry.

Evaluating the bottom line, Centene Corp maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 2.33%, while the net margin is 2.03%. These profitability ratios, combined with a Return on Equity (ROE) of -20.41%, provide a clear picture of how effectively CNC converts its operational activities into shareholder value.

In the context of the broader market, CNC competes directly with industry leaders such as HUM and MOH. With a market capitalization of $33.33B, it holds a significant position in the sector. When comparing efficiency, CNC's gross margin of N/A stands against HUM's N/A and MOH's 12.82%. Such benchmarking helps identify whether Centene Corp is trading at a premium or discount relative to its financial performance.

Centene's total revenue has shown consistent growth, with Q2 2026 revenue at $53.58 billion, up from $49.94 billion in Q1 2026. The company is expected to achieve a net profit of over $3.11 per share for fiscal 2026, reflecting confidence in future performance despite past challenges.